GENB Generate Biomedicines, Inc. - Common Stock
$16,90
Harga · Agu 19, 2026
Fundamental per Agu 6, 2026
Rentang 52M
$11–$18
82% of range
Peringkat Analis
BUY
12 analysts
Target Harga
$26
+52% upside
P/E (TTM)
—
ROE
—
Margin Laba Bersih
—
GENB Cuplikan Saham Harga, kapitalisasi pasar, P/E, EPS, ROE, utang/ekuitas, kisaran 52 minggu
Harga
$16.89
Kapitalisasi Pasar
—
P/E (TTM)
—
EPS (TTM)
—
Pendapatan (TTM)
—
Imbal Hasil Dividen
—
ROE
—
D/E Utang/Ekuitas
—
Rentang 52M
$11 – $18
GENB Grafik Harga Saham OHLCV harian dengan indikator teknis — geser, perbesar, dan sesuaikan tampilan Anda
Configure
Kinerja 10 Tahun Tren Pendapatan, laba bersih, margin, dan EPS
Pendapatan & Laba Bersih
—
EPS
—
Arus Kas Bebas
—
Margin
—
Valuasi Rasio P/E, P/S, P/B, EV/EBITDA — apakah sahamnya mahal atau murah?
Metrik
Tren 5 Tahun
GENB
Median Rekan
Profitabilitas Margin kotor, operasional, dan bersih; ROE, ROA, ROIC
Metrik
Tren 5 Tahun
GENB
Median Rekan
Kesehatan Keuangan Utang, likuiditas, solvabilitas — kekuatan neraca
Metrik
Tren 5 Tahun
GENB
Median Rekan
Pertumbuhan Pertumbuhan Pendapatan, EPS, dan Laba Bersih: YoY, CAGR 3T, CAGR 5T
Metrik
Tren 5 Tahun
GENB
Median Rekan
Efisiensi Modal Perputaran aset, perputaran persediaan, perputaran piutang
Metrik
Tren 5 Tahun
GENB
Median Rekan
GENB Konsensus Analis Opini analis bullish dan bearish, target harga 12 bulan, potensi kenaikan
BELI
12 analis
- Beli Kuat 3 25,0%
- Beli 8 66,7%
- Tahan 1 8,3%
- Jual 0 0,0%
- Jual Kuat 0 0,0%
Target Harga 12 Bulan
5 analis · 2026-08-17
Median
$25.00
← Di bawah semua target
$16.89
Rendah
$22.00
Tinggi
$30.00
Target median
$25.00
+48,0%
Target rata-rata
$25.60
+51,5%
Riwayat Pendapatan EPS aktual vs perkiraan, kejutan %, tingkat keberhasilan, tanggal pendapatan berikutnya
Kejutan Rata-rata
-0.28%
| Periode | EPS Aktual | EPS Estimasi | Kejutan |
|---|---|---|---|
| 30 Juni 2026 | $-0.52 | $-0.51 | -0.01% |
| 31 Maret 2026 | $-1.06 | $-0.51 | -0.55% |
Perbandingan rekan (sub-industri GICS) Metrik utama vs rekan sektor
| Ticker | Kapitalisasi Pasar | P/E | Pendapatan YoY | Margin Bersih | ROE | Margin Kotor |
|---|---|---|---|---|---|---|
| GENB | — | — | — | — | — | — |
| VERA | — | -10.9 | — | — | -55.9% | — |
| VCEL | $1.82B | 112.5 | 16.4% | 6.0% | 5.0% | 74.4% |
| ADMA | $4.34B | 30.4 | 19.6% | 28.8% | 33.6% | 57.4% |
| PVLA | $1.30B | -28.2 | 65.3% | -1610.6% | -110.1% | — |
| AGIO | $1.59B | -3.8 | 48.0% | -764.0% | -32.2% | — |
| STOK | $1.87B | -264.5 | 404.5% | -3.7% | -2.0% | — |
| VRDN | $3.17B | -7.7 | 23359.9% | -483.6% | -55.4% | — |
| BHVN | $1.50B | -1.6 | — | — | -310.8% | — |
| TSHA | $1.57B | -16.2 | 17.3% | -1115.3% | -44.0% | — |
Fundamental Lengkap Semua metrik per tahun — laporan laba rugi, neraca, arus kas
Neraca 20
| Metrik | Tren | 2025 |
|---|---|---|
| Cash & Equivalents | $122M | |
| Short-term Investments | $100M | |
| Prepaid Expense | $13M | |
| Current Assets | $234M | |
| PP&E (Net) | $29M | |
| PP&E (Gross) | $77M | |
| Accum. Depreciation | $48M | |
| Other Non-current Assets | $7M | |
| Total Assets | $330M | |
| Accounts Payable | $4M | |
| Current Liabilities | $82M | |
| Capital Leases | $51M | |
| Other Non-current Liabilities | $116.0K | |
| Total Liabilities | $142M | |
| Common Stock | $33.0K | |
| Retained Earnings | $-676M | |
| AOCI | $106.0K | |
| Stockholders' Equity | $-616M | |
| Liabilities + Equity | $330M | |
| Shares Outstanding | 33,116,957 |
Laporan Laba Rugi 15
| Metrik | Tren | Q2 2026 | Q1 2026 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Revenue | $6M | $7M | $10M | $9M | |
| R&D Expense | $64M | $58M | $60M | $47M | |
| SG&A Expense | $14M | $14M | $11M | $10M | |
| Operating Expenses | $78M | $71M | $70M | $57M | |
| Operating Income | $-72M | $-64M | $-60M | $-48M | |
| Interest Income | $5M | $3M | $4M | $4M | |
| Other Non-op | $4M | $2M | $3M | $4M | |
| Pretax Income | $-67M | $-62M | $-57M | $-44M | |
| Income Tax | $53.0K | $28.0K | $44.0K | $56.0K | |
| Net Income | $-67M | $-61M | $-52M | $-42M | |
| EPS (Basic) | $-0.52 | $-1.07 | $-1.94 | $-1.62 | |
| EPS (Diluted) | $-0.52 | $-1.07 | $-1.94 | $-1.62 | |
| Shares (Basic) | 128,240,371 | 64,871,295 | 32,996,506 | 32,791,905 | |
| Shares (Diluted) | 128,240,371 | 64,871,295 | 32,996,506 | 32,791,905 | |
| EBITDA | $-72M | $-64M | · | · |
Neraca 20
| Metrik | Tren | Q2 2026 | Q1 2026 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | $135M | $161M | · | · | |
| Short-term Investments | $322M | $356M | · | · | |
| Prepaid Expense | $13M | $19M | · | · | |
| Current Assets | $470M | $535M | · | · | |
| PP&E (Net) | $27M | $28M | · | · | |
| PP&E (Gross) | $82M | $79M | · | · | |
| Accum. Depreciation | $55M | $52M | · | · | |
| Other Non-current Assets | $9M | $5M | · | · | |
| Total Assets | $562M | $626M | · | · | |
| Accounts Payable | $6M | $8M | · | · | |
| Current Liabilities | $57M | $58M | · | · | |
| Capital Leases | $48M | $49M | · | · | |
| Other Non-current Liabilities | $0 | $0 | · | · | |
| Total Liabilities | $106M | $111M | · | · | |
| Common Stock | $128.0K | $128.0K | · | · | |
| Retained Earnings | $-805M | $-738M | · | · | |
| AOCI | $-129.0K | $24.0K | · | · | |
| Stockholders' Equity | $456M | $515M | · | · | |
| Liabilities + Equity | $562M | $626M | · | · | |
| Shares Outstanding | 128,269,428 | 128,192,484 | · | · |
Arus Kas 8
| Metrik | Tren | Q2 2026 | Q1 2026 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| D&A | $3M | $3M | $3M | $3M | |
| Stock-based Comp | $8M | $6M | $5M | $5M | |
| Operating Cash Flow | $-58M | $-80M | $-49M | $-53M | |
| CapEx | $933.0K | $4M | $154.0K | $751.0K | |
| Investing Cash Flow | $33M | $-260M | $-17M | $76M | |
| Financing Cash Flow | $-579.0K | $379M | $-263.0K | $21M | |
| Net Change in Cash | $-25M | $39M | $-66M | $43M | |
| Free Cash Flow | · | $-84M | · | · |
Profitabilitas 7
| Metrik | Tren | Q2 2026 | Q1 2026 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Operating Margin | -1134.2% | -887.5% | · | · | |
| Net Margin | -1065.2% | -850.6% | · | · | |
| Pretax Margin | -1064.3% | -853.9% | · | · | |
| EBITDA Margin | -1134.2% | -887.5% | · | · | |
| ROA | -23.9% | -19.6% | · | · | |
| ROE | -29.5% | -23.9% | · | · | |
| ROIC | -15.7% | -12.5% | · | · |
Likuiditas & Solvabilitas 2
| Metrik | Tren | Q2 2026 | Q1 2026 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Current Ratio | 8.3 | 9.2 | · | · | |
| Quick Ratio | 8.1 | 8.8 | · | · |
Efisiensi 1
| Metrik | Tren | Q2 2026 | Q1 2026 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | · |
Valuasi (TTM) 3
| Metrik | Tren | Q2 2026 | Q1 2026 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Market Cap | $2.16B | · | · | · | |
| P/B | 4.7 | · | · | · | |
| P / Tangible Book | 4.7 | · | · | · |
Laporan Keuangan Laporan laba rugi, neraca, arus kas — tahunan, 5 tahun terakhir
Metrik Saya Daftar pantauan pribadi Anda — baris yang dipilih dari Fundamental Lengkap
📊
Pilih metrik yang penting bagi Anda — klik ➕ di sebelah baris mana pun di Fundamental Lengkap di atas.
Pilihan Anda disimpan dan mengikuti Anda di semua ticker.
Orang dalam perusahaan 13 orang dalam · 6 pejabat · 8 direktur
| Orang Dalam | Peran | Aktivitas terakhir | Saham dimiliki | Beli 12m | Jual 12m | Bersih 12m |
|---|---|---|---|---|---|---|
| Michael Nally | Chief Executive Officer | 4 Maret 2026 P | 572.707 | 1 | 0 | $240.000 |
| Jason Silvers | President & CFO | 26 Feb. 2026 A | 1.000 | 3 | 0 | $32.000 |
| Laurie Anne Lee | Chief Medical Officer | 26 Feb. 2026 A | — | 0 | 0 | $0 |
| Beth Grous | Chief People Officer | 26 Feb. 2026 A | 300 | 1 | 0 | $4.800 |
| Gevorg Grigoryan | Chief Technology Officer | 26 Feb. 2026 A | — | 0 | 0 | $0 |
| Sean Martin | Chief Legal Officer & GC | 26 Feb. 2026 A | — | 0 | 0 | $0 |
| Stephane Bancel | Direktur | 2 Maret 2026 C | 724.160 | 0 | 0 | $0 |
| Paul Gray Parker | Direktur | 26 Feb. 2026 A | — | 0 | 0 | $0 |
| Rupert Vessey | Direktur | 26 Feb. 2026 A | — | 0 | 0 | $0 |
| Jane L Mendillo | Direktur | 26 Feb. 2026 A | 1.500 | 1 | 0 | $24.000 |
| Frances Arnold | Direktur | 26 Feb. 2026 A | — | 0 | 0 | $0 |
| Nancy A Simonian | Direktur | 26 Feb. 2026 A | — | 0 | 0 | $0 |
| Marsha Fanucci | Direktur | 26 Feb. 2026 A | — | 0 | 0 | $0 |
Orang dalam dari pengajuan SEC Form 3/4/5; bersih = hanya P/S pasar terbuka
Kepemilikan ETF Dimiliki oleh 10 ETF
Bobot mencerminkan kepemilikan ekuitas langsung (N-PORT) saja; dana berbasis leverage atau derivatif mungkin memiliki eksposur swap tambahan yang tidak ditampilkan.
| Dana | Bobot | Unit | Per tanggal | Sumber |
|---|---|---|---|---|
| VXF · VANGUARD INDEX FUNDS | — | — | 15 Juli 2026 | Harian |
| VTI · VANGUARD INDEX FUNDS | — | — | 15 Juli 2026 | Harian |
| VTWO · VANGUARD SCOTTSDALE FUNDS | — | — | 15 Juli 2026 | Harian |
| VTWV · VANGUARD SCOTTSDALE FUNDS | — | — | 15 Juli 2026 | Harian |
| VTWG · VANGUARD SCOTTSDALE FUNDS | — | — | 15 Juli 2026 | Harian |
| VTHR · VANGUARD SCOTTSDALE FUNDS | — | — | 15 Juli 2026 | Harian |
| IWN · iShares Trust | — | — | 17 Agu 2026 | Harian |
| IWO · iShares Trust | — | — | 18 Agu 2026 | Harian |
| IWM · iShares Trust | — | — | 18 Agu 2026 | Harian |
| ISCB · iShares Trust | — | — | 20 Juli 2026 | Harian |